远程医疗小组行为性咳抑制疗法用于耐火性慢性咳,使用滚动招募模型
Laurie J Slovarp1, Jane R Salois1, Kinsey Roberts1
1School of Speech, Language, Hearing, & Occupational Sciences, University of Montana, Missoula, MT, USA.
群体远程医疗行为性咳抑制疗法 (BCST) 有效治疗耐药慢性咳 (RCC). 这种方法显著改善了患者的治疗结果,并增加了获得这种重要治疗的机会.
科学领域:
- 肺部病理学 肺部病理学
- 远程医疗服务是远程医疗服务.
- 行为治疗是一种行为疗法.
背景情况:
- 耐火性慢性咳 (RCC) 给患者带来重大负担,治疗选择有限.
- 行为性咳抑制疗法 (BCST) 是有效的,但面临着可访问性挑战.
- 这项研究探讨了RCC群体远程医疗BCST对RCC的疗效.
研究的目的:
- 评估通过小组远程医疗提供的BCST的有效性.
- 评估远程医疗 BCST 对患者报告结果和咳频率的影响.
主要方法:
- 一项试点研究通过远程医疗在2-5名参与者的小组中提供了BCST.
- 参与者参加了4-6个结构化会议,重点是咳过敏和抑制技术.
- 结果包括莱斯特咳问卷 (LCQ),患者严重性全球印象 (PGI-S) 和通过智能手机应用程序监测咳.
主要成果:
- 98%的参与者超过了LCQ得分的临床重要差异最小值.
- 在治疗后1周和1个月内,LCQ得分的显著改善 (平均7.04) 持续存在 (p<0.001).
- 远程医疗 BCST 导致每小时咳率减少 68%,咳发作减少 78%.
结论:
- 群体远程医疗 (BCST) 是对耐火性慢性咳的高度有效的干预措施.
- 这种交付模式提高了RCC患者的治疗可及性和可用性.
更多相关视频
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-I: Introduction
